Arteris Names New CEO, Co-founder Departs

Ticker: AIP · Form: 8-K · Filed: 2024-09-16T00:00:00.000Z

Sentiment: neutral

Topics: leadership-change, executive-appointment, board-of-directors

TL;DR

Arteris CEO Keng Lim takes over, co-founder Armand Hassoun out.

AI Summary

Arteris, Inc. announced on September 13, 2024, changes in its executive team and board of directors. Specifically, the company appointed Keng P. Lim as Chief Executive Officer and a member of the Board of Directors, effective September 13, 2024. Additionally, the company announced the departure of Co-founder and former CEO, Armand L. P. Hassoun, from his executive roles and the Board.

Why It Matters

This filing indicates a significant leadership transition at Arteris, Inc., with a new CEO taking the helm and a co-founder stepping down, which could signal a shift in company strategy or direction.

Risk Assessment

Risk Level: medium — Leadership changes, especially involving a co-founder, can introduce uncertainty and impact strategic execution.

Key Players & Entities

FAQ

Who has been appointed as the new CEO of Arteris, Inc.?

Keng P. Lim has been appointed as the new Chief Executive Officer of Arteris, Inc.

When did the leadership changes at Arteris, Inc. become effective?

The leadership changes became effective on September 13, 2024.

Who is stepping down from executive roles and the Board of Directors at Arteris, Inc.?

Armand L. P. Hassoun, Co-founder and former CEO, is stepping down from his executive roles and the Board of Directors.

What is the primary business of Arteris, Inc. according to the filing?

Arteris, Inc. is in the Semiconductors & Related Devices industry, SIC code 3674.

What is the principal executive office address for Arteris, Inc.?

The principal executive offices are located at 900 E. Hamilton Avenue, Suite 300, Campbell, CA 95008.

Filing Stats: 789 words · 3 min read · ~3 pages · Grade level 10.8 · Accepted 2024-09-16 16:00:55

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 16, 2024 By: /s/ Nick B. Hawkins Name: Nick B. Hawkins Title: Chief Financial Officer

View on Read The Filing